HC Wainwright & Co. Maintains Buy on BioNTech, Lowers Price Target to $272

HC Wainwright & Co. analyst Robert Burns maintains BioNTech (NASDAQ:BNTX) with a Buy and lowers the price target from $283 to $272.

HC Wainwright & Co. analyst Robert Burns maintains BioNTech (NASDAQ:BNTX) with a Buy and lowers the price target from $283 to $272.

Total
0
Shares
Related Posts